-
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Rating of "Buy" by Analysts
Source: Buzz FX / 10 Mar 2025 05:36:15 America/Chicago
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads Shares of INmune Bio, Inc. ( NASDAQ:INMB - Get Free Report ) have been given a consen
Read more...